Gideon M. Blumenthal

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Sacituzumab tirumotecan (Sac-TMT) plus pembrolizumab in participants with recurrent or metastatic cervical cancer: Results from the phase 22870-002/SKB264-II-06 study

  Gynecologic Oncology · 2026-04-23 · 2 citations

• Sacituzumab tirumotecan (Sac-TMT) plus pembrolizumab (Pembro) in participants (Pts) with advanced urothelial carcinoma (UC): Results from phase 2 2870-002/SKB264-II-06 study.

  Journal of Clinical Oncology · 2026-03-01

• Sacituzumab tirumotecan in participants with advanced or metastatic urothelial carcinoma and disease progression after chemotherapy and immune checkpoint inhibitors

  Annals of Oncology · 2025-11-21 · 3 citations

• Efficacy and safety of sacituzumab tirumotecan monotherapy in patients with advanced urothelial carcinoma who progressed on or after prior anti-cancer therapies: Report from the phase 1/2 MK-2870-001 study.

  Journal of Clinical Oncology · 2025-02-10 · 12 citations

• Optimizing public-private partnerships to support clinical cancer research

  JNCI Journal of the National Cancer Institute · 2024-12-12 · 6 citations